Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
As reported for the quarter ended March 31, 2016. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | 82.3% | Unchanged | 1,930,369 | $78.4M |
| Seres Therapeutics Inc. | 16.7% | Unchanged | 599,297 | $15.9M |
| EB Eleven Biotherapeutics, Inc. | 0.6% | Unchanged | 1,907,008 | $610K |
| RE Renewable Energy Group, Inc. | 0.3% | Unchanged | 33,570 | $317K |
Loading...
